| 2024 | | Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR | 박해심 |
| 2024 | | 8-Iso-prostaglandin F2α as a biomarker of type 2 low airway inflammation and remodeling in adult asthma | 박해심 |
| 2024 | | Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia | 박해심 |
| 2024 | | Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma | 박해심, 장재혁 |
| 2024 | | Work-related asthma in adults with severe asthma from the Korean Severe Asthma Registry (KoSAR) | 박해심, 이영수 |
| 2024 | | HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity | 박해심 |
| 2024 | | The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse | 박해심, 신유섭 |
| 2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma | 박해심, 신유섭, 예영민 |
| 2024 | | Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium | 박해심 |
| 2024 | | Immune Cell-Mediated Autoimmune Responses in Severe Asthma | 박해심, 장재혁 |
| 2024 | | Real-world treatment trajectories of adults with newly diagnosed asthma or COPD | 박래웅, 박해심, 이영수 |
| 2024 | | New targets for type 2-low asthma | 박해심 |
| 2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |
| 2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma | 박해심, 신유섭, 장재혁, 최영우 |
| 2024 | | Real-World Effectiveness of Statin Therapy in Adult Asthma | 박래웅, 박해심, 양형모, 이영수, 장재혁 |
| 2024 | | Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma | 박해심, 신유섭, 유민숙, 장재혁, 최영우 |
| 2023 | | Prediction of the number of asthma patients using environmental factors based on deep learning algorithms | 박해심, 장재혁 |
| 2023 | | Corrigendum to “Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma” [Clinical Immunology 255 (2023) 109755] | 박해심 |
